Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.93 | 4.65 |
| PEG Ratio (TTM) | -0.04 | -5.74 |
| P/S Ratio (TTM) | 0.12 | 1.04 |
| P/B Ratio (TTM) | 0.36 | 1.42 |
| P/FCF Ratio (TTM) | 3.38 | 9.79 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.91 |
| Price to 5YR AVG FCF Ratio | N/A | 4.23 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.34% | -1.07% |
| ROE (TTM) | -32.02% | 3.06% |
| Net Profit Margin (TTM) | -17.74% | -1.49% |
| ROIC 5YR AVG | N/A | 9.09% |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -112.53% | 54.90% | N/A |
| Revenue | -1.14% | 4.40% | N/A |
| Net Income | -106.85% | 78.02% | N/A |
| Cash Flow | 351.31% | 6.14% | N/A |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.91 | 1.29 |
| Quick Ratio (TTM) | 2.91 | 1.29 |
| D/E Ratio (TTM) | 2.90 | 1.04 |
| Interest Coverage (TTM) | -1.15 | 4.34 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | N/A | 1.25 |
| LTL to 5YR AVG FCF | N/A | 7.75 |
| Shares Outstanding Growth 5YR AVG | N/A | 7.36% |